These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38978966)

  • 1. Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells.
    Hermansyah D; Syarifah S; Muhar AM; Putra A
    Breast Cancer (Dove Med Press); 2024; 16():319-328. PubMed ID: 38978966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
    Ryoo IG; Choi BH; Ku SK; Kwak MK
    Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
    Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
    Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
    Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
    Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
    Wu S; Wang X; Chen J; Chen Y
    Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
    Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
    Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel.
    Woo Y; Oh J; Kim JS
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
    Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A
    Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.
    Alamdar N; Farivar S; Baghaei K; Hamidieh AA; Soltaninejad H; Aghdaei HA; Zali M; Saltanatpour Z
    Curr Stem Cell Res Ther; 2024 Jan; ():. PubMed ID: 38303523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinostrobin inhibits proliferation and induces apoptosis in cancer stem-like cells through a reactive oxygen species-dependent mechanism.
    Jadaun A; Sharma S; Verma R; Dixit A
    RSC Adv; 2019 Apr; 9(21):12097-12109. PubMed ID: 35516989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors.
    Shigeishi H; Biddle A; Gammon L; Rodini CO; Yamasaki M; Seino S; Sugiyama M; Takechi M; Mackenzie IC
    J Oral Pathol Med; 2015 Mar; 44(3):201-7. PubMed ID: 25169655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44
    Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
    Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters.
    Huang W; Wen F; Gu P; Liu J; Xia Y; Li Y; Zhou J; Song S; Ruan S; Gu S; Chen X; Shu P
    Chin Med; 2022 Aug; 17(1):93. PubMed ID: 35941687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
    Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
    Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.